S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
Stock market today: European shares slip, Asian shares higher after Wall St's return to bull market
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
Graphite versus Lithium - What Investors Should Know (Ad)
6 Best Online and Direct Marketing Retail Stocks to Invest in
REV Group Shifts Into High Gear: Double-Digit Upside Ahead
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
Stock market today: European shares slip, Asian shares higher after Wall St's return to bull market
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
Graphite versus Lithium - What Investors Should Know (Ad)
6 Best Online and Direct Marketing Retail Stocks to Invest in
REV Group Shifts Into High Gear: Double-Digit Upside Ahead
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
Stock market today: European shares slip, Asian shares higher after Wall St's return to bull market
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
Graphite versus Lithium - What Investors Should Know (Ad)
6 Best Online and Direct Marketing Retail Stocks to Invest in
REV Group Shifts Into High Gear: Double-Digit Upside Ahead
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
Stock market today: European shares slip, Asian shares higher after Wall St's return to bull market
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
Graphite versus Lithium - What Investors Should Know (Ad)
6 Best Online and Direct Marketing Retail Stocks to Invest in
REV Group Shifts Into High Gear: Double-Digit Upside Ahead
NASDAQ:PDEX

Pro-Dex (PDEX) Stock Forecast, Price & News

$18.99
+0.25 (+1.33%)
(As of 06/8/2023 ET)
Compare
Today's Range
$18.63
$19.00
50-Day Range
$15.50
$19.05
52-Week Range
$14.47
$21.43
Volume
2,438 shs
Average Volume
5,338 shs
Market Capitalization
$67.41 million
P/E Ratio
14.95
Dividend Yield
N/A
Price Target
N/A

PDEX stock logo

About Pro-Dex (NASDAQ:PDEX) Stock

Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The firm specializes in medical devices and services, industrial and scientific, dental and component, repairs and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.

Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

PDEX Stock News Headlines

All Electric Commitment From GM, Volkswagen, Could Put Lithium Sector In A Supercycle
More automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...
StockNews.com Initiates Coverage on Pro-Dex (NASDAQ:PDEX)
Comparing Pro-Dex (NASDAQ:PDEX) and Teleflex (NYSE:TFX)
Soaring EV Industry Keeps Investor Focus on Lithium
The need for lithium keeps going up, up, up with the mass adoption of electric vehicles. The lithium demand for EV batteries alone is now double the rate of lithium production.
StockNews.com Begins Coverage on Pro-Dex (NASDAQ:PDEX)
PDEX Pro-Dex, Inc.
Pro-Dex (NASDAQ:PDEX) Now Covered by StockNews.com
Pro-Dex Is Growing But Expensive Given Its Risk
Why Pro-Dex, Inc. (NASDAQ:PDEX) Could Be Worth Watching
PDEX.A - | Stock Price & Latest News | Reuters
See More Headlines

PDEX Price History

PDEX Company Calendar

Last Earnings
11/15/2021
Today
6/08/2023
Fiscal Year End
6/30/2023
Next Earnings (Estimated)
8/24/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PDEX
Employees
117
Year Founded
N/A

Profitability

Net Income
$3.86 million
Pretax Margin
11.92%

Debt

Sales & Book Value

Annual Sales
$48.06 million
Cash Flow
$1.32 per share
Book Value
$6.54 per share

Miscellaneous

Free Float
2,035,000
Market Cap
$67.32 million
Optionable
Not Optionable
Beta
0.99

Key Executives

  • Richard Lee van Kirk
    President, Chief Executive Officer, COO & Director
  • Alisha K. CharltonAlisha K. Charlton
    Chief Financial Officer & Secretary













PDEX Stock - Frequently Asked Questions

How have PDEX shares performed in 2023?

Pro-Dex's stock was trading at $15.90 at the start of the year. Since then, PDEX stock has increased by 19.4% and is now trading at $18.99.
View the best growth stocks for 2023 here
.

Are investors shorting Pro-Dex?

Pro-Dex saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 11,300 shares, an increase of 18.9% from the April 30th total of 9,500 shares. Based on an average trading volume of 4,400 shares, the days-to-cover ratio is currently 2.6 days. Currently, 0.5% of the company's shares are short sold.
View Pro-Dex's Short Interest
.

When is Pro-Dex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 24th 2023.
View our PDEX earnings forecast
.

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) issued its earnings results on Monday, November, 15th. The medical instruments supplier reported $0.28 earnings per share for the quarter, meeting the consensus estimate of $0.28. The medical instruments supplier earned $9.99 million during the quarter. Pro-Dex had a net margin of 9.72% and a trailing twelve-month return on equity of 19.00%.

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

Who are Pro-Dex's major shareholders?

Pro-Dex's stock is owned by many different institutional and retail investors. Top institutional shareholders include Punch & Associates Investment Management Inc. (1.78%), Dimensional Fund Advisors LP (1.62%), LSV Asset Management (0.89%) and UBS Group AG (0.17%). Insiders that own company stock include Alisha Charlton, Katrina Marie Kramer Philp, Kirk Richard Lee Van Jr, Nicholas John Swenson, Raymond E Cabillot and William James Farrell III.
View institutional ownership trends
.

How do I buy shares of Pro-Dex?

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $18.99.

How much money does Pro-Dex make?

Pro-Dex (NASDAQ:PDEX) has a market capitalization of $67.32 million and generates $48.06 million in revenue each year. The medical instruments supplier earns $3.86 million in net income (profit) each year or $1.27 on an earnings per share basis.

How many employees does Pro-Dex have?

The company employs 117 workers across the globe.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The official website for the company is www.pro-dex.com. The medical instruments supplier can be reached via phone at (949) 769-3200, via email at investor.relations@pro-dex.com, or via fax at 949-769-3281.

This page (NASDAQ:PDEX) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -